Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction
Version 2 2024-06-03, 18:15Version 2 2024-06-03, 18:15
Version 1 2023-02-15, 22:37Version 1 2023-02-15, 22:37
journal contribution
posted on 2024-06-03, 18:15authored byT Novitskaya, S Nishat, R Covarrubias, DG Wheeler, E Chepurko, O Bermeo-Blanco, Z Xu, B Baer, H He, SN Moore, KM Dwyer, PJ Cowan, YR Su, TS Absi, J Schoenecker, LM Bellan, WJ Koch, S Bansal, I Feoktistov, SC Robson, E Gao, RJ Gumina
We show that CD39 is a critical modulator of TGF-β1-mediated fibroblast activation and cardiac remodeling following myocardial infarction via modulation of nucleotide signaling. TGF-β1-induced CD39 expression generates a negative feedback loop that attenuates cardiac fibroblast activation. In the absence of CD39 activity, collagen deposition is increased, elastin expression is decreased, and diastolic dysfunction is worsened. Treatment with ecto-apyrase attenuates the TGF-β1-induced profibrotic cardiac fibroblast phenotype, revealing a novel approach to combat post-myocardial infarction cardiac fibrosis.
History
Journal
American journal of physiology. Heart and circulatory physiology